Effect of losartan on intraocular pressure changes

Evaluation of effect of onset of losartan systemic administration on intraocular pressure in hypertensive patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210125050134N1

Enrollment

Registered

2021-12-21

Start date

2021-06-23

Completion date

Unknown

Last updated

2022-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intraocular pressure changing in hypertensive patients with normal IOP.

Interventions

Intervention group: tab. losartan 50mg administer daily for 3 month and follow up in single group.

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Inclusion criteria

Inclusion criteria: New HTN cases Monotherapy with losartan

Exclusion criteria

Exclusion criteria: Glaucoma Eye disease Comorbidity diseae exept HTN Myopia and hyperopia

Design outcomes

Primary

Measure	Time frame
Intraocular pressure changing during 1 and 3 months. Timepoint: 0 , 1month ,3months. Method of measurement: Tonometry , Goldman Slit Lamp Tonometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ali Salehi

Esfahan University of Medical Sciences

a_salehi@med.mui.ac.ir+98 31 3446 7010

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026